QWQiuru Wang

Qiuru Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Qiuru Wang has a total of 66 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Implementing Evidence‐Based, Phase‐Specific Multimodal Analgesia for Total Joint Arthroplasty: An Interprofessional Review for Nursing Practice and Management

    by Qiuru Wang, Dongmei Zhao, Jian Hu, Changjun Chen, Ting Ma, Xiaoyan Liu, Jing Yang, Pengde Kang

    Purpose: This review aims to synthesize current evidence on perioperative multimodal analgesia within enhanced recovery after surgery (ERAS) pathways for total joint arthroplasty (TJA). The primary objective is to translate this evidence into clear, actionable insights for nursing management and interprofessional collaboration, emphasizing the pivotal role of nursing professionals in orchestrating patient‐centered pain management to optimize outcomes. Methods: A structured narrative review was conducted to provide a clinically relevant synthesis of current evidence on perioperative multimodal analgesia within ERAS pathways for TJA. The review methodology was informed by established recommendations for rigorous narrative reviews, including the SANRA framework. PubMed and MEDLINE were searched for English‐language publications available up to June 2025. Studies were screened for relevance and prioritized according to methodological quality, clinical significance, and implications for nursing management and interprofessional practice, with particular emphasis on randomized controlled trials, cohort studies, clinical practice guidelines, systematic reviews, meta‐analyses, and landmark studies. Results: Multimodal analgesia, which synergistically combines pharmacologic and nonpharmacologic techniques, is the standard of care for TJA. Evidence supports phase‐specific protocols: preemptively, combining analgesics (e.g., COX‐2 inhibitors) 24–48 h preoperatively and tailoring regimens to patient risk profiles (e.g., duloxetine for central sensitization); intraoperatively, using local infiltration analgesia (LIA) as a cornerstone technique; and postoperatively, implementing a structured, nursing‐led “non‐opioid‐first” strategy with scheduled NSAIDs/acetaminophen and monitored opioid rescue protocols. For total knee arthroplasty (TKA), the combination of adductor canal block (ACB), IPACK block, and LIA is an evidence‐based strategy for optimizing analgesia while preserving motor function. Intravenous glucocorticoids are also recommended during surgery. Successful implementation is critically dependent on nursing management, including proactive patient education and expectation management, vigilant interpretive pain assessment, systematic monitoring for medication‐specific adverse effects, and coordination of mobilization with analgesic peaks. The heterogeneity of evidence underscores the need for standardized, institution‐specific protocols, implementation tools, and governance frameworks to support nursing‐led ERAS practice. Ultimately, effective analgesia functions within an interprofessional collaborative framework, in which nurses act as central coordinators facilitating communication among surgeons, anesthesiologists, and therapists to dynamically personalize care. Conclusions: The evolution toward personalized multimodal analgesia elevates the nursing role from protocol administration to essential clinical decision‐making and care coordination. Nursing leadership is indispensable for bridging evidence‐to‐practice gaps, minimizing practice variation, and ensuring patient safety. Key to success is the adoption of standardized pathways that empower nurses to lead patient education, assessment, and cross‐disciplinary communication. Future efforts should focus not only on refining analgesic evidence but also on implementation science, protocol governance, workforce competency development, and quality improvement strategies that facilitate sustainable integration into nursing workflows and consistently achieve superior analgesia, enhanced functional recovery, and minimized complications within ERAS programs.

  • Open Access

    A modified hip pericapsular nerve block on postoperative pain and functional outcome after total hip arthroplasty: a prospective, double-blind, randomized controlled study

    by Jian Hu, Qiuru Wang, Jie Hu, Chunyu Gong, Jing Yang

    Background: This study aimed to explore the efficacy and safety of the hip pericapsular nerve block (hip-PNB), which combines the anterior pericapsular nerve group (PENG) and posterior pericapsular deep-gluteal (PPD) blocks, on postoperative pain and functional outcomes after total hip arthroplasty (THA) via the posterolateral approach. Methods: Seventy patients undergoing THA were allocated to either the nerve block group (Group N, hip-PNB + sham local infiltration analgesia [LIA]) or the control group (Group C, sham hip-PNB + LIA). The primary outcome was cumulative morphine consumption in the first 24 h postoperatively. Secondary outcomes included visual analog scale pain scores at rest and during movement postoperatively, time to first rescue analgesia, cumulative morphine consumption during hospitalization, opioid consumption during surgery, postoperative recovery, and postoperative complications. Results: Compared with Group C, Group N consumed significantly less morphine in the first 24 h (10 [0, 10] mg vs. 10 [10, 20] mg; P < 0.001) and throughout hospitalization (10 [0, 20] mg vs. 20 [20, 30] mg; P < 0.001) and had less opioid consumption perioperatively. Group N also had significantly lower pain scores at rest and during movement in the first 24 h, required rescue analgesia later, and had faster recovery postoperatively than Group C. No significant intergroup differences were observed in quadriceps muscle strength or postoperative complication rates.Conclusions: Compared to LIA, hip-PNB has better postoperative analgesia and enhances recovery in patients undergoing THA.


  • Comparison of Adductor Canal Block Before Versus After Total Knee Arthroplasty in Terms of Pain, Stress, and Functional Outcomes

    by Qiuru Wang, Jian Hu, Changjun Chen, Ting Ma, Jing Yang, Pengde Kang

    Background: Whether an adductor canal block (ACB) is more effective when administered before or after total knee arthroplasty (TKA) is unclear. This study compared pain, stress, and functional outcomes between patients who received the block before surgery and those who received the block after surgery. Methods: In this double-blinded trial, 100 patients at our hospital were randomized to receive an ACB at either 30 minutes before general anesthesia or postoperatively in the post-anesthesia care unit (PACU). All patients received periarticular local infiltration analgesia during surgery. The 2 groups were compared with respect to the primary outcome, the postoperative consumption of morphine as rescue analgesia, and in terms of the secondary outcomes, including the time from the end of surgery to the first rescue analgesia or discharge, intraoperative and postoperative stress, postoperative pain, functional recovery, the incidence of chronic pain, and complications. Results: All included patients were Asian (Chinese) in race/ethnicity. The 2 groups had similar demographic information. Compared with the postoperative ACB, the preoperative ACB was associated with significantly lower morphine consumption within the first 24 hours postoperatively and lower total morphine consumption. It was also associated with a longer time until the first rescue analgesia, lower intraoperative consumption of opioids and inhaled anesthetic, fewer episodes of hypertension during surgery, a lower rate of rescue analgesia in the PACU, lower levels of cortisol and adrenocorticotropic hormone in serum on the morning of postoperative day 1, lower pain on a visual analog scale while at rest or during motion within 12 hours postoperatively, better range of knee motion on postoperative day 1, and a lower incidence of chronic pain at 3 months postoperatively. The 2 groups did not differ significantly with respect to postoperative ambulation distance, time until discharge, or complication rates. Conclusions: Administering an ACB before rather than after TKA may lead to lower opioid consumption during hospitalization, lower intraoperative and postoperative stress responses, better pain relief during hospitalization, and a lower incidence of chronic pain at 3 months postoperatively. Level of Evidence: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.


  • Efficacy of preemptive multimodal analgesia initiated at various time points before total knee arthroplasty: a prospective, double-blind randomized controlled trial

    by Qiuru Wang, Xingcheng Li, Jian Hu, Changjun Chen, Jing Yang, Pengde Kang

    Introduction Preemptive multimodal analgesia (PMA) is commonly employed for pain control after total knee arthroplasty (TKA). However, the optimal timing for initiating PMA remains unclear. This study aimed to compare the efficacy of PMA administered at different time points before TKA. Materials and methods In this prospective, double-blind, placebo-controlled, randomized trial, 120 patients who underwent TKA were randomized into three groups. PMA (200 mg celecoxib and 150 mg pregabalin administered every 12 h) was initiated 48 h (group A), 24 h (group B), and 1 h (group C) before surgery. The primary outcome was the postoperative administration of morphine hydrochloride as a rescue analgesic. Secondary outcomes included time to first rescue analgesia, postoperative pain assessed using the visual analog scale (VAS), functional recovery assessed by knee motion range and ambulation distance, time until hospital discharge, and complication rates. Results Compared with group C, groups A and B exhibited significantly lower morphine consumption within 24 h after surgery, lower total morphine consumption, longer time to first rescue analgesia, and superior range of knee motion on the day of surgery. Groups A and B did not exhibit significant differences in these outcomes. The three groups did not differ significantly in postoperative VAS pain scores, ambulation distance, length of hospital stay, or complication rates. Conclusions In comparison with PMA starting at 1 h preoperatively, initiating PMA at 24 and 48 h preoperatively provided better postoperative pain relief. Considering the aim of minimizing the amount of ineffective medication received by patients, initiating PMA at 24 h preoperatively may be a more favorable option for patients undergoing TKA. However, the clinical significance of our results and the optimal starting time for PMA require further investigation.


  • Efficacy of Diosmin in Reducing Lower-Extremity Swelling and Pain After Total Knee Arthroplasty

    by Qiuru Wang, Qunhua Jin, Lijun Cai, Chengcheng Zhao, Pengfei Feng, Jie Jia, Weihua Xu, Qirong Qian, Zheru Ding, Jianzhong Xu, et al.

    Background: Many patients experience lower-extremity swelling following total knee arthroplasty (TKA), which impedes recovery. Diosmin is a semisynthetic flavonoid that is often utilized to treat swelling and pain caused by chronic venous insufficiency. We aimed to evaluate the efficacy and safety of diosmin in reducing lower-extremity swelling and pain as well as in improving functional outcomes following TKA. Methods: This study was designed as a randomized, controlled multicenter trial and conducted in 13 university-affiliated tertiary hospitals. A total of 330 patients undergoing TKA were randomized to either receive or not receive diosmin postoperatively. The diosmin group received 0.9 g of diosmin twice per day for 14 consecutive days starting on the day after surgery, whereas the control group received neither diosmin nor a placebo postoperatively. The primary outcome was lower-extremity swelling 1, 2, 3, and 14 days postoperatively. The secondary outcomes were postoperative pain assessed with use of a visual analogue scale, Hospital for Special Surgery score, range of knee motion, levels of the inflammatory biomarkers C-reactive protein and interleukin-6, and complications. Results: At all postoperative time points, diosmin was associated with significantly less swelling of the calf, thigh, and upper pole of the patella as well as with significantly lower pain scores during motion. However, no significant differences in postoperative pain scores at rest, Hospital for Special Surgery scores, range of motion, levels of inflammatory biomarkers, or complication rates were found between the diosmin and control groups. Conclusions: The use of diosmin after TKA reduced lower-extremity swelling and pain during motion and was not associated with an increased incidence of short-term complications involving the outcomes studied. However, further studies are needed to continue exploring the efficacy and safety of diosmin use in TKA. Level of Evidence: Therapeutic Level I. See Instructions for Authors for a complete description of levels of evidence.


  • Open Access

    Influencing factors of hidden blood loss after primary total hip arthroplasty through the posterior approach: a retrospective study

    by Lijun Cai, Liyile Chen, Chengcheng Zhao, Qiuru Wang, Pengde Kang

    Background: Total hip arthroplasty (THA) is an excellent treatment for the end-stage hip disease, and perioperative blood management strategies have been effectively applied to this procedure. However, many patients still experience anemia after the operation, which is usually overlooked by orthopedic surgeons due to the hidden blood loss (HBL) in the perioperative period. Therefore, the objective of this study was to evaluate HBL in patients undergoing primary THA using the posterior approach and to explore its influencing factors. Methods: A retrospective analysis of 707 patients who underwent primary THA through the posterior approach was conducted in our hospital from January 2020 to January 2022. By applying Gross’s and Nadler’s formula, the HBL was calculated. Six quantitative variables (age, body mass index, surgical duration, albumin loss, preoperative hemoglobin, and hemoglobin loss) as well as four qualitative variables (gender, American Society of Anesthesiologists class, major preoperative diagnosis, and hypertension) of patients were analyzed using multivariate linear regression. Results: The HBL was recorded at 700.39 ± 368.59 mL. As a result of multivariate linear regression analysis, it was determined that body mass index, surgical duration, and hemoglobin loss were all significant risk factors for HBL, whereas preoperative hemoglobin was considered a protective factor. It has been demonstrated that HBL is not significantly correlated with age, albumin loss, gender, ASA class, or major preoperative diagnosis, but it also did not differ from HBL by hypertension. Conclusions: Hidden blood Loss (HBL) in patients after primary total hip arthroplasty (THA) using the posterior approach is large and significant. When optimizing the perioperative management of THA, orthopedic surgeons should keep in mind HBL and its influencing factors, especially for patients with high body mass indexes, long surgical durations, and low preoperative hemoglobin levels. Trial registration: This study was registered in the Chinese Clinical Trial Registry (ChiCTR2100053888) in 02/12/2021, http://www.chictr.org.cn.


  • Open Access

    Efficacy of Adding Acetaminophen to Preemptive Multimodal Analgesia in Total Knee Arthroplasty: A Double‐blinded Randomized Study

    by Qiuru Wang, Ting Ma, Liying Wang, Chengcheng Zhao, Pengde Kang

    Objective: Preemptive multimodal analgesia is a frequently utilized method for controlling pain after total knee arthroplasty (TKA). So far, no studies have specifically examined the efficacy of adding acetaminophen to preemptive multimodal analgesia in TKA. The current work aimed to assess the efficacy of adding acetaminophen to preemptive multimodal analgesia for clinical pain management after TKA.Methods: This was a double‐blinded randomized study including 80 cases randomized to the acetaminophen and control groups, respectively. The acetaminophen group was administered celecoxib at 400 mg, pregabalin at 150 mg, and acetaminophen at 300 mg 2 h before TKA. Control patients were administered celecoxib, pregabalin, and placebo. The primary outcome was postsurgical use of morphine hydrochloride for rescue analgesia. Secondary outcomes included the time to the initial rescue analgesia, postsurgical pain as determined by a visual analogue scale (VAS), functional recovery as reflected by the range of knee motion and ambulation distance, hospitalization duration, and complication rates. Continuous data with normal and skewed distributions were compared by the Student's t test and the Mann–Whitney U test, respectively. Categorical variables were compared by the Pearson's chi‐squared test.Results: The control and acetaminophen groups were comparable in postoperative 0–24 h morphine consumption (11.3 ± 6.5 mg vs 12.3 ± 7.7 mg, P = 0.445) and total morphine consumption (17.3 ± 10.1 mg vs 19.3 ± 9.4 mg, P = 0.242). Additionally, time to the initial rescue analgesia, postoperative VAS score at any time point, postoperative functional recovery of the knee, and hospitalization duration were similar in both groups. Both groups also had similar occurrence rates of postoperative complications.Conclusions: In this study, adding acetaminophen to preoperative preemptive multimodal analgesia did not decrease postoperative morphine use or ameliorate pain relief. The efficacy of adding acetaminophen to preemptive multimodal analgesia in TKA need to be further explored in future studies.


  • Open Access

    Effects of magnesium sulfate on periarticular infiltration analgesia in total knee arthroplasty: a prospective, double-blind, randomized controlled trial

    by Chengcheng Zhao, Liying Wang, Liyile Chen, Qiuru Wang, Pengde Kang

    Background: To investigate whether adding magnesium sulfate to a periarticular infiltration analgesia (PIA) cocktail could improve pain control and functional outcomes in patients undergoing total knee arthroplasty (TKA).Methods: Ninety patients were randomly assigned to the magnesium sulfate and control groups, with 45 patients in each group. In the magnesium sulfate group, patients were given a periarticular infusion of a cocktail of analgesics consisting of epinephrine, ropivacaine, magnesium sulfate, and dexamethasone. The control group received no magnesium sulfate. The primary outcomes consisted of visual analogue scale (VAS) pain scores, postoperative morphine hydrochloride consumption for rescue analgesia, and time to first rescue analgesia. Secondary outcomes were postoperative inflammatory biomarkers (IL-6 and CRP), postoperative length of stay, and knee functional recovery (assessed by knee range of motion, quadriceps strength, daily mobilization distance, and time to first straight-leg raising). Tertiary outcomes included the postoperative swelling ratio and complication rates.Results: Within 24 h of surgery, patients in the magnesium sulfate group had markedly lower VAS pain scores during motion and at rest. After the addition of magnesium sulfate, the analgesic effect was dramatically prolonged, leading to a reduction in morphine dosage within 24 h and the total morphine dosage postoperatively. Postoperative inflammatory biomarker levels were significantly reduced in the magnesium sulfate group compared with the control. There were no considerable differences between the groups in terms of the postoperative length of stay and knee functional recovery. Both groups had similar postoperative swelling ratios and incidences of complications.Conclusions: The addition of magnesium sulfate to the analgesic cocktail for PIA can prolong postoperative analgesia, decrease the consumption of opioids, and effectively alleviate early postoperative pain after TKA.Trial registration: Chinese Clinical Trial Registry, ChiCTR2200056549. Registered on 7 February 2022,https://www.chictr.org.cn/showproj.aspx?proj=151489.